Dr. Kiss's training began in New York City where he received his undergraduate degree with honors from Columbia College and medical school training at Columbia University College of Physicians & Surgeons. He then moved to Boston to complete his ophthalmology residency and surgical vitreoretinal fellowship, both at Harvard Medical School and the Massachusetts Eye & Ear Infirmary. At Harvard, Dr. Kiss was select by the faculty to serve as the Chief Retina Fellow. Dr. Kiss was then recruited back to New York City to join the vitreoretinal faculty at Weill Cornell Medical College and assume the role of Director of Clinical Research in the Department of Ophthalmology.

Dr. Kiss's clinical interests include complex vitreoretinal surgery and treatment of age?related macular degeneration and diabetic retinopathy. His clinical and translational research focuses on four broad areas: retinal imaging, ocular gene therapy, novel therapeutic targets for ocular neovascularization, and genetic markers for retinal diseases. Dr. Kiss has participated as a principal investigator in over two-dozen prospective clinical trials and laboratory investigations. He has authored over 200 scientific publications, given over 100 invited lectureships worldwide, and serves on the Editorial Board and as a Scientific Reviewer to a number of major journals. Dr. Kiss has won numerous academic and scientific awards including the Heed Ophthalmic Foundation Fellowship, the Ronald G. Michels Foundation Fellowship, the Paul Kayser International Fellowship, and the Research to Prevent Blindness Physician-Scientists Award. Dr. Kiss has been named to several regional and national Top Doctors lists, including The Ophthalmologist worldwide Top 40 Under 40, Castle Connolly's Top Doctors in America, and New York Super Doctors Rising Stars.